Paion AG (PA8)
XDUS
Real-time Data
06:00 AM
Day's Range
0.059552 wk Range
0.00800Overview - PA8 - Paion AG
Key Statistics
Valuation
Enterprise Value
9.72M
P/E (Trailing)
‪-0.74‬
PEG Ratio
‪0.0054‬
Price / Book
‪-0.13‬
EV / EBITDA
‪2.25‬
Profitability
Gross Margin
‪33.24%‬
Profit Margin
‪94.10%‬
Operating Margin
‪7.82%‬
Return on Assets
‪-1.51%‬
Return on Equity
‪-8.75%‬
Ownership
Shares Outstanding
7.13M
Price stats
50-Day Avg
‪0.0626‬
200-Day Avg
‪0.0528‬
Peers - PA8 - Paion AG
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on XDUS.
- PA8XDUSPaion AG+79.83%52-week change-0.74P/E (Trailing)‪94.10%‬Profit Margin
- IP40XDUSInnoCan Pharma Corporation+90.63%52-week change-5.40P/E (Trailing)‪89.92%‬Profit Margin
- 6CWXDUSCharlottes Web Holdings Inc.+74.64%52-week change-1.32P/E (Trailing)‪43.48%‬Profit Margin
- 20MPXDUSMountain Valley MD Holdings Inc.+68.45%52-week change-3.55P/E (Trailing)—Profit Margin
- HLSXDUSAIC Mines Limited+63.90%52-week change—P/E (Trailing)—Profit Margin
- 4KF0XDUSGlass House Brands Inc.+53.83%52-week change-14.00P/E (Trailing)‪42.28%‬Profit Margin
- E7PXDUSIndivior Pharmaceuticals, Inc.+53.57%52-week change18.33P/E (Trailing)‪80.14%‬Profit Margin
Profile Summary - PA8 - Paion AG
About
Paion AG is a pharmaceutical company primarily engaged in the development and commercialization of innovative treatments in anesthesia and critical care. The company focuses on creating drugs that address serious medical conditions, aiming to improve patient outcomes and safety. Paion's flagship product, Remimazolam,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
